Would you believe that studies have shown that an extract from eggplant can cure cancer? That’s cure, not just improve the majority of skin cancers, usually in two to three months or less? This may seem like groundbreaking information, but researchers have known about it for nearly 20 years.
Actually, extracts from plants of the Solanaceae family, (which includes eggplant, tomato, potato, bell peppers and tobacco) were reported effective for treating cancer as long ago as 1825. But scientific investigation of these anti-cancer effects didn’t happen until the second half of the 20th century, and the first few years of the 21st.
Results in no-time flat
The first reported study compared the effects of a topical eggplant extract called BEC with a placebo on two different types of skin cancer—basal cell and squamous cell—and actinic keratosis, a condition characterized by small, rough, yellow or brownish patches of skin that almost always occur on sun-exposed skin of individuals over 50.
Thirty individuals had basal cell cancers, usually a form that spreads locally if untreated. All 28 of the patients using BEC had complete regression of all of their basal cell cancers (some had more than one) in three to 13 weeks. None of the patients using placebo had improvement after 14 weeks.
Twenty of the volunteers had squamous cell cancers, a form which starts and spreads locally but can metastasize. Again, all of the patients using BEC (20 this time) had complete regression of their squamous cell cancers in three to 11 weeks. There were no placebo treatments in this group.
The actinic keratosis group experienced the same effects: Of the 24 in the BEC-treated group, 100 percent had complete regression, this time in just one week to a month. None of the 12 patients using placebo had any improvement at all in 14 weeks.
In another small study, which used a slightly different version of BEC called BEC2, 13 individuals with 24 basal cancers had 83 percent of those cancers completely regress in less than two months. Five people with squamous cell cancers also had 83 percent of their cancers completely regress within one to three months. And eight individuals with actinic keratosis had 100 percent regression in just two to six weeks.
Cost-effective and non-invasive
In a letter dated April 23, 2002, Drs. Rino Cerio and Sangeeta Punjabi of the Dermatology Department of the Royal London Hospital describe their experience participating in trials using a form of the extract called BEC5 to treat both invasive and non-invasive forms of basal cell carcinoma. The first was a placebo-controlled, double-blind, multi-centered study of 94 patients. The second trial with 41 individuals was done only at Royal London Hospital, and was mostly to assess safety, so no placebo was used. The doctors reported that in both trials, approximately 78 percent experienced complete regression within eight weeks.
The doctors noted that with twice daily use, only a few patients reported skin irritation and redness. They pointed out that the cosmetic outcome is comparable to that resulting from surgical excision.
The doctors concluded: In our view and experience BEC5 is a topical preparation which is safe and effective, ideal therapy for outpatient treatment It is a cost-effective treatment for both primary and secondary skin cancer care. And follow-up research on patients who have used BEC shows that once their cancer or actinic keratosis goes away, it doesn’t recur.
The backdoor approach to cancer treatment
BEC5 is a name for a mixture of 1/3 solasonine and 1/3 solamargine in the triglycoside form, and 1/3 diglycosides and monoglycosides of these two basic molecules.
Solasonine and solamargine themselves are actually very similar (but not identical to) human cholesterol and steroid molecules.
By themselves, solasonine and solamargine don’t have anti-cancer activity because they can’t penetrate into cells, cancerous or normal. That’s why just eating the foods that contain these compounds won’t eliminate your skin cancer or even reduce your risk of getting it. In order for them to be effective, they need to be able to get into the cells. That’s where the glycosides come in.
Glycoside is a term used to describe molecules with various simple sugars attached to them. One of these simple sugars, called rhamnose, selectively latches on to receptors present only in skin cancer cell membranes and in actinic keratosis. When you combine the solasonine and solamargine with rhamnose, they can get into the cells where they cause cancer cell death by destroying cell components called lysosomes.
Normal cells escape any harm, since the BEC5 can’t get into them.
80,000 success stories
According to Dr. Bill Cham, who has developed BEC since the 1980s, BEC5 is effective at extremely low-doses and is safe to use even very frequently.
Dr. Cham writes: BEC5 is applied at least twice daily to the skin and may be applied much more frequently if rapid regression of the tumor is required. Some patients apply [it] up to 10 times daily. The cosmetic results after using BEC5 are very impressive and over 80,000 patients have now used BEC5 successfully.
Also, please note that BEC5 does not contain the part of the eggplant that can cause nightshade sensitivity in arthritis sufferers.
Remember: What’s reported here are preliminary research results concerning BEC5 and squamous cell cancer, basal cell cancer, and actinic keratosis. Even though these results are very good, they may not apply to you.
As always, consult with a physician skilled and knowledgeable in nutritional and natural medicine if you’d like to try BEC5. And since skin cancer (especially squamous cell cancer) can be very dangerous if neglected, it’s always wisest to consult a dermatologist, too. JVW